-
公开(公告)号:KR20180043407A
公开(公告)日:2018-04-27
申请号:KR20187011138
申请日:2011-05-13
Applicant: ARRAY BIOPHARMA INC
Inventor: ANDREWS STEVEN WADE , CONDROSKI KEVIN RONALD , HAAS JULIA , JIANG YUTONG , KOLAKOWSKI GABRIELLE R , SEO JEONGBEOB , YANG HONG WOON , ZHAO QIAN
IPC: C07D487/22 , A61K31/519 , A61P25/00 , A61P35/00 , C07D471/22 , C07D498/22
CPC classification number: C07D498/22 , A61K31/519 , C07D471/22 , C07D487/04 , C07D487/22 , C07D519/00
Abstract: 식의화합물:및약제학적으로허용가능한그의염, 여기서링 A, 링 B, W, m, D, R, R, R, R, 및 Z은본 명세서에서정의된바와같음, 은 Trk 키나제의저해제이고통증, 암, 염증, 신경퇴행성질환및 특정의감염성질환의치료에서유용하다.
-
公开(公告)号:JP2017082004A
公开(公告)日:2017-05-18
申请号:JP2017020927
申请日:2017-02-08
Applicant: アレイ バイオファーマ、インコーポレイテッド , Array Biopharma Inc , アレイ バイオファーマ、インコーポレイテッド
Inventor: ALLEN SHELLEY , ANDREWS STEVEN WADE , CONDROSKI KEVIN RONALD , JULIA HAAS , LILY HUANG , JIANG YUTONG , TIMOTHY KERCHER , SEO JEONGBEOB
IPC: C07D487/04 , A61K31/519 , A61K31/5377 , A61P25/04 , A61P25/28 , A61P29/00 , A61P33/00 , A61P35/00
CPC classification number: C07D487/04 , A61K31/519 , A61K31/5377 , C07D453/02 , C07D471/22 , C07D498/22 , C07D519/00
Abstract: 【課題】Trkキナーゼ阻害剤を提供すること。【解決手段】R1、R2、R3、R4、X、Y、およびnが本明細書で定められた意味を有する式(I)の化合物およびその塩は、Trkキナーゼの阻害剤であり、Trkキナーゼ阻害剤で処理することができる、疼痛、癌、炎症、神経変性疾患、ならびにある特定の感染性疾患等の疾患の治療に有用である。例えば、本発明の化合物、またはその薬学的に許容される塩、および薬学的に許容される希釈剤または担体を含む、薬学的組成物もまた提供される。【選択図】なし
-
3.Macrocyclic carboxylic acid and acylsulfonamide as inhibitor of hcv replication 有权
Title translation: 作为丙型肝炎病毒复制的抑制剂的大环羧酸和氨基磺酰胺公开(公告)号:JP2010248236A
公开(公告)日:2010-11-04
申请号:JP2010155686
申请日:2010-07-08
Applicant: Array Biopharma Inc , Intermune Inc , アレイ・バイオファーマ・インコーポレーテッド , インターミューン・インコーポレーテッド
Inventor: BLATT LAWRENCE M , WENGLOWSKY STEVEN MARK , ANDREWS STEVEN WADE , JIANG YUTONG , KENNEDY APRIL LAYNE , CONDROSKI KEVIN RONALD , JOSEY JOHN ANTHONY , STENGEL PETER JOHN , MADDURU MACHENDER R , DOHERTY GEORGE ANDREW , WOODARD BENJAMIN T
IPC: C07K5/087 , A61K20060101 , A61K31/4418 , A61K31/7056 , A61K31/7105 , A61K38/00 , A61K38/21 , A61K38/22 , A61K39/395 , A61K45/00 , A61K47/34 , A61K47/48 , A61P1/16 , A61P31/14 , A61P43/00 , C07D487/04 , C08H1/00
CPC classification number: C07D487/04 , A61K38/00 , C07K5/0804
Abstract: PROBLEM TO BE SOLVED: To provide a compound for treating hepatitis C virus (HCV) infection, its synthesizing method, its composition and a treating method using it. SOLUTION: There are provided compounds of general formulas I-IX as well as compositions including pharmaceutical compositions containing a subject compound. There are further provided treatment methods including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of the subject compound or composition. COPYRIGHT: (C)2011,JPO&INPIT
Abstract translation: 要解决的问题:提供治疗丙型肝炎病毒(HCV)感染的化合物,其合成方法,其组成和使用它的治疗方法。 解决方案:提供通式I-IX的化合物以及包含含有主题化合物的药物组合物的组合物。 还提供了治疗方法,包括治疗丙型肝炎病毒感染的方法和治疗肝纤维化的方法,所述方法通常涉及向有需要的个体施用有效量的受试化合物或组合物。 版权所有(C)2011,JPO&INPIT
-
公开(公告)号:JP2017082018A
公开(公告)日:2017-05-18
申请号:JP2017029007
申请日:2017-02-20
Applicant: アレイ バイオファーマ、インコーポレイテッド , Array Biopharma Inc , アレイ バイオファーマ、インコーポレイテッド
Inventor: ANDREWS STEVEN WADE , CONDROSKI KEVIN RONALD , JULIA HAAS , JIANG YUTONG , GABRIELLE R KOLAKOWSKI , SEO JEONGBEOB , YANG HONG-WOON , ZHAO QIAN
IPC: C07D471/22 , A61K31/519 , A61K31/5395 , A61P25/00 , A61P25/04 , A61P29/00 , A61P31/00 , A61P35/00 , A61P43/00 , C07D498/22
CPC classification number: C07D498/22 , A61K31/519 , C07D471/22 , C07D487/04 , C07D487/22 , C07D519/00
Abstract: 【課題】Trkキナーゼのインヒビターであって、そして、疼痛、癌、炎症、神経変性疾患、および特定の感染性疾患の治療において有用である化合物を提供すること【解決手段】下記式I[式中において、環A、環B、W、m、D、R2、R2a、R3、R3a、およびZは、本願の明細書に記載されているとおりに定義されるものである]の化合物、および製薬上許容されうるその塩は、Trkキナーゼのインヒビターであって、そして、疼痛、癌、炎症、神経変性疾患、および、特定の感染性疾患の治療において、有用である。【選択図】なし
-
公开(公告)号:ES2718043T3
公开(公告)日:2019-06-27
申请号:ES17163978
申请日:2011-05-13
Applicant: ARRAY BIOPHARMA INC , ARRAY BIOPHARMA INC
Inventor: ANDREWS STEVEN WADE , CONDROSKI KEVIN RONALD , HAAS JULIA , JIANG YUTONG , KOLAKOWSKI GABRIELLE R , SEO JEONGBEOB , YANG HONG-WOON , ZHAO QIAN
IPC: C07D487/04 , A61K31/519 , C07D471/22 , C07D487/22 , C07D498/22 , C07D519/00
-
6.MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULFONAMIDES AS INHIBITORS OF HCV REPLICATION 审中-公开
Title translation: 作为丙型肝炎病毒复制的抑制剂的大环羧酸和乙酰磺胺公开(公告)号:WO2005037214A3
公开(公告)日:2005-11-03
申请号:PCT/US2004033970
申请日:2004-10-13
Applicant: INTERMUNE INC , ARRAY BIOPHARMA INC
Inventor: BLATT LAWRENCE M , WENGLOWSKY STEVEN MARK , ANDREWS STEVEN WADE , JIANG YUTONG , KENNEDY APRIL LAYNE , CONDROSKI KEVIN RONALD , JOSEY JOHN ANTHONY , STENGEL PETER JOHN , MADDURU MACHENDER R , DOHERTY GEORGE ANDREW , WOODARD BENJAMIN T
IPC: A61K20060101 , A61K38/00 , C07D487/04 , C08H1/00
CPC classification number: C07D487/04 , A61K38/00 , C07K5/0804
Abstract: The present invention provides compounds of the general formulas I-IX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The present invention further provides treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Abstract translation: 本发明提供了通式I-IX的化合物,以及包含主题化合物的组合物,包括药物组合物。 本发明还提供治疗方法,包括治疗丙型肝炎病毒感染的方法和治疗肝纤维化的方法,所述方法通常涉及向有需要的个体施用有效量的主题化合物或组合物。
-
7.Macrocyclic compounds as TRK kinase inhibitors 有权
Title translation: Makrocyclische Verbindungen als TRK-Kinasehemmer公开(公告)号:EP2918588B1
公开(公告)日:2017-05-03
申请号:EP15150036
申请日:2011-05-13
Applicant: ARRAY BIOPHARMA INC
Inventor: ANDREWS STEVEN WADE , CONDROSKI KEVIN RONALD , HAAS JULIA , JIANG YUTONG , KOLAKOWSKI GABRIELLE R , SEO JEONGBEOB , YANG HONG-WOON , ZHAO QIAN
IPC: C07D487/04 , A61K31/519 , C07D471/22 , C07D498/22 , C07D519/00
CPC classification number: C07D498/22 , A61K31/519 , C07D471/22 , C07D487/04 , C07D487/22 , C07D519/00
Abstract: Compounds of Formula I : and pharmaceutically acceptable salts thereof, wherein ring A, ring B, W, m, D, R 2 , R 2a , R 3 , R 3a , and Z are as defined herein, are inhibitors of Trk kinases and are useful in the treatment of pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.
Abstract translation: 其中环A,环B,W,m,D,R 2,R 2a,R 3,R 3a和Z如本文所定义的式I化合物及其药学上可接受的盐是Trk激酶的抑制剂并且是 用于治疗疼痛,癌症,炎症,神经退行性疾病和某些传染病。
-
8.MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULFONAMIDES AS INHIBITORS OF HCV REPLICATION 有权
Title translation: 氨基丁二酸二甲酯的制备方法公开(公告)号:EP1680137A4
公开(公告)日:2010-04-28
申请号:EP04795169
申请日:2004-10-13
Applicant: INTERMUNE INC , ARRAY BIOPHARMA INC
Inventor: BLATT LAWRENCE M , WENGLOWSKY STEVEN MARK , ANDREWS STEVEN WADE , JIANG YUTONG , KENNEDY APRIL LAYNE , CONDROSKI KEVIN RONALD , JOSEY JOHN ANTHONY , STENGEL PETER JOHN , MADDURU MACHENDER R , DOHERTY GEORGE ANDREW , WOODARD BENJAMIN T
IPC: C07D487/04 , A61K20060101 , A61K38/00 , C08H1/00
CPC classification number: C07D487/04 , A61K38/00 , C07K5/0804
-
公开(公告)号:DK3205654T3
公开(公告)日:2019-04-15
申请号:DK17163978
申请日:2011-05-13
Applicant: ARRAY BIOPHARMA INC
Inventor: ANDREWS STEVEN WADE , CONDROSKI KEVIN RONALD , HAAS JULIA , JIANG YUTONG , KOLAKOWSKI GABRIELLE R , SEO JEONGBEOB , YANG HONG-WOON , ZHAO QIAN
IPC: C07D487/04 , A61K31/519 , C07D471/22 , C07D487/22 , C07D498/22 , C07D519/00
-
10.
公开(公告)号:AU2017221802B2
公开(公告)日:2019-04-04
申请号:AU2017221802
申请日:2017-08-30
Applicant: ARRAY BIOPHARMA INC
Inventor: ALLEN SHELLEY , ANDREWS STEVEN WADE , BLAKE JAMES F , BRANDHUBER BARBARA J , HAAS JULIA , JIANG YUTONG , KERCHER TIMOTHY , KOLAKOWSKI GABRIELLE R , THOMAS ALLEN A , WINSKI SHANNON L
IPC: C07D401/14 , A61K31/4155 , A61K31/416 , A61K31/4162 , A61P25/00 , C07D231/40 , C07D231/54 , C07D401/12 , C07D403/02 , C07D403/04 , C07D403/14 , C07D405/12 , C07D405/14 , C07D413/12 , C07D453/02
Abstract: [0010131 Compounds of Formula I: or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis and pelvic pain syndrome.
-
-
-
-
-
-
-
-
-